Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
39046 POSTS 0 COMMENTS
Many patients with mild traumatic brain injury report persistent functional limitations one year after injury

Functional Limitations Persist One Year After Mild TBI

0
Fifty-three percent of patients with mild traumatic brain injury report functional limitations at 12 months
The oldest and sickest Americans are least likely to be able to afford home care

Most Older Adults Would Have to Liquidate Assets for Home Care

0
Fewer older adults with significant disabilities could afford extensive care
Providing assistance for physician impairment and rehabilitation is addressed in a position statement issued by the American College of Physicians and published online June 4 in the Annals of Internal Medicine.

ACP Issues Position on Response to Physician Impairment

0
Rehabilitated doctors should be reintegrated into practice as long as patient safety not compromised
Peripherally inserted central catheters are frequently used in hospitalized patients with stage 3b or greater chronic kidney disease (estimated glomerular filtration rate

Peripherally Inserted Central Catheters Often Used in CKD

0
Despite guidelines, placement of PICCs common in those with advanced chronic kidney disease
For callers reporting heroin use

Many Buprenorphine Prescribers Not Offering New Appointments

0
However, for those offering new appointments, wait times were not long to receive buprenorphine
Decreases in nontraumatic lower-extremity amputation have plateaued in recent years among adults with end-stage renal disease and diabetes

Decline in Nontraumatic Lower-Extremity Amputation Slowing

0
Decline in NLEA among patients with end-stage renal disease with diabetes stabilized since 2013
The U.S. Food and Drug Administration took a good look at the safety and effectiveness of cannabidiol products on Friday

FDA Takes Hard Look at CBD

0
CBD products have swamped the market due to change in federal law, not because of new medical evidence
Pembrolizumab is noninferior to chemotherapy for overall survival among patients with programmed death ligand 1

ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer

0
For patients with PD-L1 combined positive score of ≥10, pembrolizumab prolongs overall survival
People living with HIV have an increased risk for cardiovascular disease

Guidelines Issued for Addressing Heart Disease Risk in HIV

0
Individuals with HIV have significantly higher rates of CVD, may have underuse of statins, antithrombotics
In recent years

Number, Rate of Detergent Pod Exposures Modestly Declined

0
Increases seen from 2012 to 2015 in children <6, but 18 percent decrease observed 2015 to 2017